There are 749 resources available
Brigatinib vs crizotinib in patients with ALK inhibitor-naive advanced ALK+ NSCLC: Updated results from the phase III ALTA-1L trial
Presenter: Ross Camidge
Session: Presidential session
Resources:
Slides
Webcast
Invited Discussant LBA1
Presenter: Sai-Hong Ou
Session: Presidential session
Resources:
Slides
Webcast
LBA2 - TATTON expansion cohorts: A phase Ib study of osimertinib plus savolitinib in patients (pts) with EGFR-mutant, MET-positive NSCLC following disease progression on a prior EGFR-TKI
Presenter: Ji-Youn Han
Session: Presidential session
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA2
Presenter: David Planchard
Session: Presidential session
Resources:
Slides
Webcast
LBA3 - IMbrave150: Efficacy and safety results from a ph III study evaluating atezolizumab (atezo) + bevacizumab (bev) vs sorafenib (Sor) as first treatment (tx) for patients (pts) with unresectable hepatocellular carcinoma (HCC)
Presenter: Ann-Lii Cheng
Session: Presidential session
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA3
Presenter: Ian Chau
Session: Presidential session
Resources:
Slides
Webcast
The evolving IO treatment landscape in UC
Presenter: Cora Sternberg
Session: Merck Pfizer Alliance - Recent advances and future possibilities with immunotherapy in renal and urothelial cancers
Resources:
Slides
KEYNOTE-181: Pembrolizumab vs chemotherapy in patients (pts) with advanced/metastatic adenocarcinoma (AC) or squamous cell carcinoma (SCC) of the esophagus as second-line (2L) therapy
Presenter: Sung-Bae Kim
Session: Mini Oral session - Gastrointestinal tumours
Resources:
Slides
Webcast
Pembrolizumab + chemotherapy for advanced G/GEJ adenocarcinoma (GC): The phase III KEYNOTE-062 study
Presenter: Hyun Cheol Chung
Session: Mini Oral session - Gastrointestinal tumours
Resources:
Slides
Webcast
Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial
Presenter: Do-Youn Oh
Session: Mini Oral session - Gastrointestinal tumours
Resources:
Slides
Webcast